Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
I would treat this as an urgent patient-safety and governance event, not as an earnings-management problem. A suspected fatal or life-threatening adverse effect affecting potentially hundreds of patients is sufficient to trigger immediate escalation, investigation, and regulator contact.Read the full answer
CEO Crisis Action Plan: 48-Hour Protocol The Core Decision Framework Non-negotiable principle: Patient safety and legal compliance override short-term financial concerns. The "wait for more data" position is legally reckless and ethically indefensible.Read the full answer